TCUP Costs & Access Barriers

Last verified: April 2026

Product Costs

TCUP products typically cost $40–$70 per item, depending on product type, cannabinoid concentration, and dispensary. This is roughly 3 times the cost of comparable hemp-derived THC products available in Texas smoke shops, convenience stores, and online retailers.

Why No Insurance?

Cannabis remains a Schedule I controlled substance under federal law. Insurance companies — which are regulated at both state and federal levels — cannot cover Schedule I substances. This means every dollar a TCUP patient spends on medical cannabis comes entirely out of pocket, regardless of the patient's insurance plan, income level, or medical necessity.

Not Tax-Deductible

Under IRS Code Section 280E, expenses related to the trafficking of Schedule I or II controlled substances are not deductible. While 280E was designed to target illegal drug dealers, the IRS has applied it to legal state-licensed cannabis businesses and patients alike. TCUP patients cannot deduct medical cannabis costs on their federal tax returns, even with a valid prescription.

The Dispensary Access Problem

Three dispensaries serve the entire state of Texas — 268,596 square miles, the second-largest state in the nation. All three have retail locations concentrated in the I-35 corridor (Austin, San Antonio, Houston, Plano). Patients in West Texas, the Panhandle, East Texas, and the Rio Grande Valley are hundreds of miles from the nearest pickup location.

Will HB 46 Help?

Yes — eventually. HB 46 expands dispensary licenses from 3 to 15 and authorizes satellite pickup locations. DPS selected 9 new licensees in December 2025 and 3 more in April 2026, with regional distribution requirements to prevent clustering. However, new dispensaries must become operational within 24 months of license award, meaning the earliest new locations may not open until late 2026 or early 2027.

The Physician Bottleneck

Approximately 800 physicians are registered in the Compassionate Use Registry of Texas (CURT) out of roughly 80,000 board-certified physicians in the state — less than 1%. This is the single largest structural barrier to TCUP access.

Several factors contribute to low physician participation:

• Federal liability concerns — Texas uses a "prescription" model, and prescribing a Schedule I substance creates theoretical DEA exposure
• Institutional policies — many hospital systems and large medical groups prohibit physicians from participating in CURT
• Stigma — some physicians remain reluctant to associate their practice with cannabis
• Administrative burden — CURT registration and ongoing compliance requirements deter participation
• Specialty requirement — physicians must be board-certified in a specialty relevant to the patient's qualifying condition

Enrollment Rate: Far Below Average

Only 135,470 patients are enrolled in TCUP as of late 2025 — just 0.44% of Texas's 31 million residents. The national average enrollment rate for states with medical cannabis programs is 2.1%. If Texas enrolled at the national average, TCUP would have approximately 651,000 patients — nearly five times current enrollment.

Before the HB 46 expansion, only about 4,000 patients per month were actively purchasing products from dispensaries, a fraction of the registered patient base. Many patients register but never fill a prescription due to cost, distance, or product limitations.

Competition from Hemp-Derived THC

Texas's $5.5 billion hemp-derived THC market is TCUP's most formidable competitor. Hemp-derived products containing delta-8, delta-9, and other THC isomers are:

• Cheaper — estimated at one-third the cost of TCUP products
• More accessible — sold in thousands of smoke shops, convenience stores, and online
• No prescription required — available to anyone 21+ (or with no age verification online)
• Available immediately — no physician visit, no registration, no waiting period

For many Texans with qualifying conditions, the rational economic choice is to purchase hemp-derived THC products rather than navigate the TCUP system. This competition suppresses TCUP enrollment and undermines the regulated medical market.

The Firearms Question

Federal law under 18 U.S.C. §922(g)(3) prohibits any person who is "an unlawful user of or addicted to any controlled substance" from possessing firearms or ammunition. Because cannabis remains federally illegal, TCUP patients may face a conflict between their medical cannabis prescription and their Second Amendment rights.

Barriers Summary